StockMatchby Pulse Deck

Latest evidence-based view

BBC · SELL

BBC: managing your position takes priority over adding more. 1 month -16.02% · 3 months -20.65% · 1 year +29.95%.

BUYOriginal source alertSELLEvidence-reviewed stance240Alert timeframe

BBC: managing your position takes priority over adding more.

1 month -16.02% · 3 months -20.65% · 1 year +29.95%. Taken together, the verified indicators provide stronger negative evidence.

A short-term rebound is possible, but the current balance of evidence favors reducing exposure.

If you hold a position, reduce it gradually. Delay new purchases until the three-month trend recovers.

Market evidence

40.82Reference price
-16.021-month return
-20.653-month return
29.951-year return
42.352-week range position
2026-10-19T13:30:00+00:00Market data as of

Instrument profile

Virtus Biotech Clinical Trials ETF

DescriptionVirtus Biotech Clinical Trials ETFSecurity TypefundSecurity SubtypeetfSectorMiscellaneousIndustryInvestment Trusts/Mutual FundsBeta 1Y1.42Expense Ratio Percent0.65Nav39.327